MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · International journal of clinical and experimental pathology · 2022

Initial panel of immunocytochemical markers for identification of primary carcinoma site for effusions and peritoneal washings from women.

Takano Gustavo Henrique Soares, Amorim Rivadávio Fernandes, Ferreira Vânia Moraes, Vianna Leonora Maciel de Souza, de Castro Tercia Maria Mendes Lousa, Carneiro Marcos de Vasconcelos, Oliveira Ísis de Araújo, Motoyama Andrea Barretto, Carneiro Fabiana Pirani

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

In women, most malignant effusions are from breast and ovary primary carcinomas that have metastasized to body cavity fluids (pleural, peritoneal and pericardial). When carcinoma is diagnosed in effusions, it is not possible to identify its site of origin solely by cytology (morphology); therefore, immunocytochemistry is used as a complementary method. There are no immunocytochemical markers with 100% sensitivity and specificity for identifying carcinoma primary site. The markers most used are TTF-1 for the lung, GATA-3 for the breast, and PAX-8 for the ovary. The aim of this study was to evaluate the sensitivity and specificity of a panel including these markers for detecting the primary site of carcinoma in effusions.

METHODS

Samples of pleural, pericardial, and peritoneal effusions and peritoneal washings with carcinoma of known primary site from women (n = 60) and men (n = 18) were prepared by using the cell block method, and immunocytochemistry was performed to evaluate the expression of primary site markers (TTF-1, PAX-8, and GATA-3).

RESULTS

In women, the breast was the most frequent primary site of metastatic carcinoma to both pleural and pericardial cavities, followed by the lung, whereas the ovary was the most frequent primary site of carcinoma within peritoneal effusions and washings, followed by the gastrointestinal tract (stomach or intestine). The expected profiles for carcinomas of the most common primary sites were: breast (GATA-3 (+), PAX-8 (-), TTF-1 (-)), ovary (PAX-8 (+), GATA-3 (-), TTF-1 (-)), lung (TTF-1 (+), PAX-8 (-) GATA-3 (-)) and gastrointestinal tract (PAX-8 (-), GATA-3 (-), TTF-1 (-)). These were observed in 88.23% (45/51) of women's samples with carcinoma from these primary sites. By using TTF-1 as the sole primary site marker, 6.25% of carcinomas of primary site other than the lung would have been misdiagnosed.

CONCLUSION

An initial panel of markers including GATA-3, PAX-8, and TTF-1 allows, with high sensitivity and specificity, the identification or exclusion of frequent primary sites of carcinoma in effusions from women. Our results highlight the importance of using a panel of markers to avoid misidentification of the primary site of tumor.

Для цитирования: Takano Gustavo Henrique Soares, Amorim Rivadávio Fernandes, Ferreira Vânia Moraes, Vianna Leonora Maciel de Souza, de Castro Tercia Maria Mendes Lousa, Carneiro Marcos de Vasconcelos, Oliveira Ísis de Araújo, Motoyama Andrea Barretto, Carneiro Fabiana Pirani. Initial panel of immunocytochemical markers for identification of primary carcinoma site for effusions and peritoneal washings from women.. International journal of clinical and experimental pathology. 2022.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.